8AR2

Solution structure of TLR5 transmembrane and cytoplasmic juxtamembrane regions

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	1000 uM [U-13C; U-15N] protein, 220 mM [U-2H] DPC, 20 mM potassium phosphate, 4 mM TCEP, 0.05 % w/v sodium azide, 1 mM TSP	95% H2O/5% D2O	50 mM	6.0	AMBIENT atm	313	Bruker AVANCE III 800
2	2D 1H-13C HSQC aliphatic constant time	1000 uM [U-13C; U-15N] protein, 220 mM [U-2H] DPC, 20 mM potassium phosphate, 4 mM TCEP, 0.05 % w/v sodium azide, 1 mM TSP	95% H2O/5% D2O	50 mM	6.0	AMBIENT atm	313	Bruker AVANCE III 800
3	2D 1H-13C HSQC aliphatic	1000 uM [U-13C; U-15N] protein, 220 mM [U-2H] DPC, 20 mM potassium phosphate, 4 mM TCEP, 0.05 % w/v sodium azide, 1 mM TSP	95% H2O/5% D2O	50 mM	6.0	AMBIENT atm	313	Bruker AVANCE III 800
4	2D 1H-13C HSQC aromatic	1000 uM [U-13C; U-15N] protein, 220 mM [U-2H] DPC, 20 mM potassium phosphate, 4 mM TCEP, 0.05 % w/v sodium azide, 1 mM TSP	95% H2O/5% D2O	50 mM	6.0	AMBIENT atm	313	Bruker AVANCE III 800
5	3D HNCO	1000 uM [U-13C; U-15N] protein, 220 mM [U-2H] DPC, 20 mM potassium phosphate, 4 mM TCEP, 0.05 % w/v sodium azide, 1 mM TSP	95% H2O/5% D2O	50 mM	6.0	AMBIENT atm	313	Bruker AVANCE III 800
6	3D HNCA	1000 uM [U-13C; U-15N] protein, 220 mM [U-2H] DPC, 20 mM potassium phosphate, 4 mM TCEP, 0.05 % w/v sodium azide, 1 mM TSP	95% H2O/5% D2O	50 mM	6.0	AMBIENT atm	313	Bruker AVANCE III 800
7	3D HN(CO)CA	1000 uM [U-13C; U-15N] protein, 220 mM [U-2H] DPC, 20 mM potassium phosphate, 4 mM TCEP, 0.05 % w/v sodium azide, 1 mM TSP	95% H2O/5% D2O	50 mM	6.0	AMBIENT atm	313	Bruker AVANCE III 800
8	3D HCCH-TOCSY	1000 uM [U-13C; U-15N] protein, 220 mM [U-2H] DPC, 20 mM potassium phosphate, 4 mM TCEP, 0.05 % w/v sodium azide, 1 mM TSP	95% H2O/5% D2O	50 mM	6.0	AMBIENT atm	313	Bruker AVANCE III 800
9	3D hCCH-TOCSY constant time	1000 uM [U-13C; U-15N] protein, 220 mM [U-2H] DPC, 20 mM potassium phosphate, 4 mM TCEP, 0.05 % w/v sodium azide, 1 mM TSP	95% H2O/5% D2O	50 mM	6.0	AMBIENT atm	313	Bruker AVANCE III 800
10	3D 1H-15N NOESY	1000 uM [U-13C; U-15N] protein, 220 mM [U-2H] DPC, 20 mM potassium phosphate, 4 mM TCEP, 0.05 % w/v sodium azide, 1 mM TSP	95% H2O/5% D2O	50 mM	6.0	AMBIENT atm	313	Bruker AVANCE III 800
11	3D 1H-13C NOESY aliphatic	1000 uM [U-13C; U-15N] protein, 220 mM [U-2H] DPC, 20 mM potassium phosphate, 4 mM TCEP, 0.05 % w/v sodium azide, 1 mM TSP	95% H2O/5% D2O	50 mM	6.0	AMBIENT atm	313	Bruker AVANCE III 800
12	3D 1H-13C NOESY aliphatic constant time	1000 uM [U-13C; U-15N] protein, 220 mM [U-2H] DPC, 20 mM potassium phosphate, 4 mM TCEP, 0.05 % w/v sodium azide, 1 mM TSP	95% H2O/5% D2O	50 mM	6.0	AMBIENT atm	313	Bruker AVANCE III 800
13	2D CBHD aromatic	1000 uM [U-13C; U-15N] protein, 220 mM [U-2H] DPC, 20 mM potassium phosphate, 4 mM TCEP, 0.05 % w/v sodium azide, 1 mM TSP	95% H2O/5% D2O	50 mM	6.0	AMBIENT atm	313	Bruker AVANCE III 800
14	3D hCCH-COSY aromatic	1000 uM [U-13C; U-15N] protein, 220 mM [U-2H] DPC, 20 mM potassium phosphate, 4 mM TCEP, 0.05 % w/v sodium azide, 1 mM TSP	95% H2O/5% D2O	50 mM	6.0	AMBIENT atm	313	Bruker AVANCE III 800
15	2D CGCO	1000 uM [U-13C; U-15N] protein, 220 mM [U-2H] DPC, 20 mM potassium phosphate, 4 mM TCEP, 0.05 % w/v sodium azide, 1 mM TSP	95% H2O/5% D2O	50 mM	6.0	AMBIENT atm	313	Bruker AVANCE III 800
16	2D CGN	1000 uM [U-13C; U-15N] protein, 220 mM [U-2H] DPC, 20 mM potassium phosphate, 4 mM TCEP, 0.05 % w/v sodium azide, 1 mM TSP	95% H2O/5% D2O	50 mM	6.0	AMBIENT atm	313	Bruker AVANCE III 800
17	2D 1H-15N HSQC	180 uM [U-15N] protein, 40 mM DPC, 30 mM potassium phosphate, 4 mM TCEP, 0.05 % w/v sodium azide, 1 mM TSP, 30 mg/mL dGpG, 100 mM potassium chloride	95% H2O/5% D2O	160 mM	6.0	AMBIENT atm	318	Bruker AVANCE III 600
18	2D 1H-15N IPAP-HSQC	180 uM [U-15N] protein, 40 mM DPC, 30 mM potassium phosphate, 4 mM TCEP, 0.05 % w/v sodium azide, 1 mM TSP, 30 mg/mL dGpG, 100 mM potassium chloride	95% H2O/5% D2O	160 mM	6.0	AMBIENT atm	318	Bruker AVANCE III 600

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE III	800
2	Bruker	AVANCE III	600

NMR Refinement
Method	Details	Software
torsion angle dynamics		CYANA

NMR Ensemble Information
Conformer Selection Criteria	structures with the least restraint violations
Conformers Calculated Total Number	100
Conformers Submitted Total Number	10
Representative Model	1 (closest to the average)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	structure calculation	CYANA	3.98.13	Guntert, Mumenthaler and Wuthrich
2	processing	TopSpin	3.0	Bruker Biospin
3	chemical shift assignment	CARA	1.9.7.1	Keller and Wuthrich
4	peak picking	CARA	1.9.7.1	Keller and Wuthrich
5	processing	qMDD	3.2	Maxim Mayzel, Krzysztof Kazimierczuk, Vladislav Orekhov
6	data analysis	MOLMOL		Koradi, Billeter and Wuthrich

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.